La miastenia gravis generalizada supone una carga significativa para los pacientes y sus cuidadores, afectando su autonomía, calidad de vida
Leer más
La compañía biotecnológica Argenx ha colaborado en el desarrollo de esta herramienta como parte de su compromiso con la mejora
Leer más
Se trata del primer y único fragmento de anticuerpo IgG Fc dirigido específicamente contra el receptor neonatal Fc (FcRn), aprobado
Leer más
La Organización Médica Colegial de España (OMC), a través de su Fundación para la Formación (FFOMC) y argenx han presentado
Leer más| Cookie | Duración | Descripción |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |